Back to Speakers

George Wyatt is the Managing Director of Wyatt Health Management, which he founded in 2002 after a very successful 20-year career in the pharmaceutical industry. He held a number of senior positions in the industry, including Director, Market Access and Policy Development for Bristol-Myers Squibb Canada. Prior to being involved in the pharmaceutical sector, Mr. Wyatt was employed with a provincial government and worked both in the bureaucracy and on the political side.

Mr. Wyatt holds a B.Sc. from Memorial University of Newfoundland, and an M.B.A. in Marketing and Strategic Management from the Schulich School of Business at York University in Toronto where he won the Graduate Business Council Gold Medal for Academic Achievement. He has also studied health policy at the Faculty of Medicine at the University of Toronto.
Company Profile and Biosimilar Leadership.

Wyatt Health Management is a full-service Canadian pricing and reimbursement consultancy. We are the leading agency in Canada for biosimilars. We have extensive experience working with clients from Europe, Asia and the Americas. We pioneered the entry of biosimilars in Canada and have never looked back. We have a team of pharmacologists, health economists, and clinicians ready to meet your needs. Both payers and manufacturers have looked to us to solve the issues associated with biosimilars in Canada. You can count on us too!

The company’s mission is to be the most respected reimbursement consulting firm in Canada, going beyond commercial success, so that patients are not left behind.